BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27901585)

  • 1. A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.
    Thiruchselvam T; Malik S; Le Foll B
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):197-214. PubMed ID: 27901585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The endogenous opioid system and drug addiction].
    Maldonado R
    Ann Pharm Fr; 2010 Jan; 68(1):3-11. PubMed ID: 20176158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anesthesiological management of the drug-abusing parturient: relevance of maternal substance abuse for obstetric anesthesia].
    Kork F; Kleinwächter R; Kaufner L; Weib-Gerlach E; Siedentopf JP; Spies C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Oct; 46(10):640-6. PubMed ID: 22020568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the Ghrelin System in Drug Addiction.
    Zallar LJ; Farokhnia M; Tunstall BJ; Vendruscolo LF; Leggio L
    Int Rev Neurobiol; 2017; 136():89-119. PubMed ID: 29056157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study.
    Leroy C; Karila L; Martinot JL; Lukasiewicz M; Duchesnay E; Comtat C; Dollé F; Benyamina A; Artiges E; Ribeiro MJ; Reynaud M; Trichard C
    Addict Biol; 2012 Nov; 17(6):981-90. PubMed ID: 21812871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addiction and withdrawal--current views.
    Melichar JK; Daglish MR; Nutt DJ
    Curr Opin Pharmacol; 2001 Feb; 1(1):84-90. PubMed ID: 11712541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol and nicotine interactions: pre-clinical models of dependence.
    Tarren JR; Bartlett SE
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):146-154. PubMed ID: 27740856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the endogenous cannabinoid system in drug addiction.
    Parolaro D; Rubino T
    Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
    Wilkins JN
    Schizophr Bull; 1997; 23(2):215-28. PubMed ID: 9165632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse.
    Cross SJ; Lotfipour S; Leslie FM
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):171-185. PubMed ID: 27532746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances.
    Serre F; Fatseas M; Denis C; Swendsen J; Auriacombe M
    Addict Behav; 2018 Aug; 83():123-129. PubMed ID: 29428330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple substance use among young males.
    Kapusta ND; Plener PL; Schmid R; Thau K; Walter H; Lesch OM
    Pharmacol Biochem Behav; 2007 Feb; 86(2):306-11. PubMed ID: 17126388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heightened Dopaminergic Response to Amphetamine at the D
    Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
    Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging Impaired Response Inhibition and Salience Attribution in Human Drug Addiction: A Systematic Review.
    Zilverstand A; Huang AS; Alia-Klein N; Goldstein RZ
    Neuron; 2018 Jun; 98(5):886-903. PubMed ID: 29879391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic reward response relates to age of first drunkenness and feedback response in at-risk youth.
    Weiland BJ; Zucker RA; Zubieta JK; Heitzeg MM
    Addict Biol; 2017 Mar; 22(2):502-512. PubMed ID: 26732626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
    Latt N; Jurd S; Tennant C; Lewis J; Macken L; Joseph A; Grochulski A; Long L
    Australas Psychiatry; 2011 Aug; 19(4):354-9. PubMed ID: 21851228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural substrates of cue reactivity: association with treatment outcomes and relapse.
    Courtney KE; Schacht JP; Hutchison K; Roche DJ; Ray LA
    Addict Biol; 2016 Jan; 21(1):3-22. PubMed ID: 26435524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.